The herpes simplex virus, HSV-1, appears to reprogram the brain’s resident immune cells, according to a new mouse study. ScienceAlert reported that the finding may help explain how the virus contributes to the inflammation seen in diseases of cognitive decline. The work was done only in animals, and it is not yet known whether the same thing happens in people.
The study, published in PLOS Pathogens, focused on microglia, specialized immune cells that continually monitor the brain. They detect threats, clear out dead cells and damaged tissue, and prune connections between neurons.
The team infected mice with HSV-1 and examined their brains six days later, using genetic analysis and imaging to map where the virus was and how the immune system responded. The virus stayed confined to discrete spots in the brainstem instead of spreading throughout it. Markers of microglial activation were higher in the regions that contained the virus.
The activated cells also showed sharply increased interferon signaling, a process in which immune cells release proteins as chemical warnings to their neighbors. Compared with animals given a mock treatment, the proportion of interferon-responsive microglia was over 30 times higher in the infected mice, which suggests the alarm system may have gone into overdrive.
Affected cells also showed reduced activity in genes tied to normal brain maintenance, monitoring and communication. The authors describe this as a redistribution of microglial identities, a shift away from routine upkeep toward a specialized antiviral state.
Neuroscientist Christy Niemeyer of the University of Colorado Anschutz said the cells move into emergency defense mode when the virus enters the brain. That helps fight the infection, she said, but may compromise their everyday functions even after the virus is gone. She added that the virus is changing the molecular programs that control how these cells work, not just triggering inflammation.
The researchers wrote that suppressing those maintenance programs could impair the cells’ ability to engulf debris and clear toxic factors, and could promote protein clumping, adding to the risk of neurodegenerative disease after infection.
ScienceAlert noted that earlier research has implicated HSV-1 in triggering Alzheimer’s disease and possibly even doubling the risk of dementia. The new study offers a possible mechanism: a viral infection that sets off lasting changes in how the brain’s immune cells behave. The authors say loss of these maintenance programs has been reported in several neurological disorders, including Alzheimer’s disease and multiple sclerosis.
The caveats are significant. The immune response was seen in a small number of mice, and the animals were euthanized as part of the experiment, so there is no proof they would have developed neurodegeneration. Whether the changes persist after the infection clears is also unknown. Niemeyer called that an important open question.
If similar responses occur in people infected with HSV-1, the pathway could be a critical contributor to cognitive decline, ScienceAlert wrote. The researchers say the next step is to test how durable these shifts in microglial state are, given what they describe as growing evidence linking HSV-1 to long-term neuroinflammation.
For now, the study adds a piece to the puzzle of how a common virus might affect the brain. It does not show that herpes causes dementia, and it offers no guidance for patients.
Around Prague, based on reporting by ScienceAlert